VCX went from $40 to $550 in days on NYSE. I watched it from Vienna. I couldn't buy a single share — not because I don't understand the risks, but because MiFID II says no.
I watched it on TradingView. From Vienna. Unable to buy a single share.
The rest of the piece is what I was thinking before the listing. The data above is just what happened after.
The Fund I Can't Touch
I've been watching the Fundrise Innovation Fund with the kind of fascination you'd reserve for a party you weren't invited to. Since its launch, it's been quietly building a portfolio of late-stage private companies — think OpenAI, Anthropic, Databricks — the exact names that keep showing up in every serious conversation about where the next decade of value is going to be created. And the performance? It's been holding up in ways that a lot of public market alternatives haven't.
Here's my problem: I'm European. And thanks to MiFID II — the EU's well-intentioned but increasingly frustrating financial regulatory framework — products like the Fundrise Innovation Fund are simply not available to me as a retail investor. Not because I can't afford it. Not because I don't understand the risks. But because Brussels decided that this category of investment needs to stay behind a wall.
I get the logic. I really do. But in 2026, it's starting to feel less like protection and more like a structural disadvantage.
What Fundrise Is Actually Doing
For those unfamiliar — Fundrise started as a real estate crowdfunding platform, but the Innovation Fund is a different beast. It's a non-traded interval fund that gives everyday American investors access to private equity-style exposure in high-growth tech companies. We're talking about the Anthropics and OpenAIs of the world — companies that, if and when they go public, will likely do so after most of their explosive early growth has already happened.
That's the key insight here. The IPO used to be the moment retail investors got to participate in a company's growth story. Now it's often closer to the exit. By the time a company like OpenAI lists publicly — if it ever does — institutional investors, VCs, and sovereign wealth funds will have already captured the most asymmetric part of the return curve.
Fundrise is trying to change that, at least for Americans. And while the fund is still young and the track record is being written in real time, the concept itself is exactly right.
The real democratization of finance isn't about zero-commission trades on meme stocks. It's about giving ordinary people access to the same asset classes that have been quietly making institutions very, very rich for decades.
The MiFID II Wall
MiFID II came into force in 2018 with genuinely good intentions — increase transparency, protect retail investors, standardize markets across the EU. And in many ways it worked. But one of its side effects is a kind of paternalistic gatekeeping around alternative investment products that makes it almost impossible for European retail investors to access anything resembling private equity or complex structured funds.
The result? If you're a European high-net-worth individual or institutional player, you can still get in. You just need to qualify as a "professional investor." But for the rest of us — people who are financially literate, who do their research, who understand what an interval fund is and what liquidity risk means — the door is largely closed.
Meanwhile, American retail investors with as little as $10 can start building exposure to the private tech economy through platforms like Fundrise. That gap is real, and it compounds over time.
But Let's Be Honest About the Risks
I want to be fair here, because I think the risk argument deserves genuine engagement rather than dismissal.
Private market investments are illiquid. The Fundrise Innovation Fund is an interval fund — meaning redemptions are limited to specific windows, and even then they're not guaranteed. If you need your money, you might not be able to get it. That's a fundamentally different risk profile than buying shares in a listed company.
Valuation is also murky. Private companies don't have the same mark-to-market discipline that public listings impose. A $80 billion valuation on OpenAI is a number constructed by a handful of investors in a room — not discovered through the friction of a public market. That introduces real uncertainty around what you're actually buying.
And then there's concentration and selection risk. Not every fund curating "hot private tech" will pick winners. Many won't. The brand names in the portfolio today don't guarantee returns tomorrow.
These are real concerns. I'm not brushing them off.
But Then I Think About Wirecard
Here's where my patience with the "protection" argument runs thin.
Wirecard was a publicly listed company on the Frankfurt Stock Exchange. It was part of the DAX — Germany's blue-chip index. It was audited, regulated, covered by analysts, and held by institutional and retail investors alike. And it was a complete fraud.
€1.9 billion that simply didn't exist. Retail investors lost everything. The system that was supposed to protect them — public listings, regulatory oversight, audit requirements — failed spectacularly.
So when I hear that European regulators are keeping me away from a fund investing in Anthropic because it's "too risky" for retail investors... I think about Wirecard. I think about the fact that the listed, "safe," regulated world is not actually the safe harbor it's marketed as.
At some point, you have to let adults make informed decisions about their own risk. The information is out there. The tools to understand these products exist. The argument that retail investors categorically cannot handle private equity exposure starts to feel less like protection and more like market segmentation that benefits the people already inside the wall.
What I Actually Want to See
I'm not calling for zero regulation — that's not the answer either. But I do think Europe needs a serious conversation about creating a tiered retail access framework for alternative investments. Something like a self-certified sophisticated investor category with mandatory disclosures, risk acknowledgment, and investment caps — similar to what the UK was experimenting with before their own regulatory pendulum swung.
Private equity has been the single best-performing asset class over the last 20 years for those with access to it. The data is not ambiguous. Keeping that locked away from European retail investors while institutional money compounds inside it is not consumer protection. It's incumbency protection.
VCX just went from $40 to $550 — and climbing. I watched it from Vienna, unable to buy a single share.
The gap isn't getting smaller. And European regulators are not moving fast enough to close it.